CCardio-Oncology3d ago

Correction: CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis

Joshua D. Mitchell·Jorge E. Cortes·John Boehmer·John Gorcsan·Shunsuke Eguchi·Yoshiyuki Orihara·Nalina Dronamraju·Sonja Dhani·Stefan Faderl·Tara L. Lin·Geoffrey L. Uy·Jeffrey E. Lancet·Michael Pfeiffer

Read at Cardio-Oncology

Tags

Chemotherapy-induced cardiotoxicity and mitigationCardiology and Cardiovascular Medicine